Venture Capital and how to find, approach and work with VC firms

The following company is one of the companies presenting at the 22nd Annual Investors Choice Venture Capital Conference.  It is part of a group of presenting companies that are classified as being Early Stage – Founder or Angel backed and/or having annual sales less than $1 million

Phoenix Pharmalabs, Inc. – Drug Discovery  Logan, UT
 
Phoenix PharmaLabs, Inc. uses a proprietary technology (“ChemMod”) to modify the structures of existing, best-selling drugs into new chemical entities for further drug development.  The ChemMod technology is broadly enabling and can revolutionize drug discovery by creating “new and improved” versions of 80% of current blockbuster drugs. PPL has applied this technology to create a first (“Opioids”) technology bundle comprised of novel analogs of conventional opioids (e. g., morphine) – with greatly improved properties relative to those drugs.